Evidence map›Paper›PMID 39350415›Full record

ArticleCurrent topics in medicinal chemistry2025

Bioassay Guided Isolation and α-Glucosidase Inhibition Studies of a New Sesquiterpene from

Hamida K M Al Rabani, Ajmal Khan, Tania Shamim Rizvi, Liaqat Ali, Javid Hussain, Fazal Mabood, Sobia Ahsan Halim, Asaad Khalid, Ahmed Al-Harrasi

Abstract read
PubMed Publisher
In one paragraph

Article in Current topics in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hamida K M Al RabaniDepartment of Biological Sciences and Chemistry, University of Nizwa, Nizwa-616, Sultanate of Oman.
Ajmal KhanNatural and Medical Sciences Research Center, University of Nizwa, Nizwa-616, Sultanate of Oman.
Tania Shamim RizviNatural and Medical Sciences Research Center, University of Nizwa, Nizwa-616, Sultanate of Oman.
Liaqat AliDepartment of Chemistry, University of Mianwali, Mianwali-42200, Pakistan.
Javid HussainDepartment of Biological Sciences and Chemistry, University of Nizwa, Nizwa-616, Sultanate of Oman.
Fazal MaboodDepartment of Chemistry, University of Swat, Pakistan.
Sobia Ahsan HalimNatural and Medical Sciences Research Center, University of Nizwa, Nizwa-616, Sultanate of Oman.
Asaad KhalidSubstance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan 45142, Saudi Arabia.
Ahmed Al-HarrasiNatural and Medical Sciences Research Center, University of Nizwa, Nizwa-616, Sultanate of Oman.

Funding

University of Nizwa UoN/CAS/IF/2023/8
6 · The paper itself

Abstract

aimsThe aim of the current study was to explore the anti-diabetic potential of

methodsAll the fractions of

resultsThe preliminary screening showed that all the fractions including

conclusionThe results of the present study indicated that the newly purified secondary metabolite, Jardenol, can be a promising anti-diabetic compound.

Indexed as

alpha-GlucosidasesGlycoside Hydrolase InhibitorsSesquiterpenesBiological AssayDose-Response Relationship, DrugMolecular Docking SimulationMolecular StructurePlant ExtractsStructure-Activity Relationshipalpha-GlucosidasesGlycoside Hydrolase InhibitorsPlant ExtractsSesquiterpenesMolecular docking.Ochradenus aucheriPhytochemical investigationsResedaceaeStructure elucidationα-glucosidase inhibition

Identifiers

PMID39350415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.